Work

Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy

Year: 2016

Type: article

Study design: Observational Study

Source: International Journal of Antimicrobial Agents

DOI: 10.1016/j.ijantimicag.2016.03.017

Authors: Catherine Orrell, Andrzej Bienczak, Karen Cohen, David Bangsberg, Robin Wood, Gary Maartens, Paolo Denti

Institutions: University of Cape Town, Institute of Infectious Disease and Molecular Medicine, Harvard University, Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2345871675

FWCI: 3.386

Cites: 24

Cited by: 23

Related to: 10